| 公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1 | 2020 | Improved antithrombotic activity and diminished bleeding side effect of a PEGylated alphaIIb beta 3 antagonist, disintegrin | Kuo Y.-J.; Chang Y.T.; Chung C.-H.; Chuang W.-J.; TUR-FU HUANG | Toxins | 9 | 8 | |
2 | 2019 | From discovery of snake venom disintegrins to a safer therapeutic antithrombotic agent | Kuo Y.-J.; Chung C.-H.; TUR-FU HUANG | Toxins | 22 | 18 | |
3 | 2019 | A novel alpha iIb beta 3 antagonist from snake venom prevents thrombosis without causing bleeding | Kuo Y.-J.; Chung C.-H.; Pan T.-Y.; Chuang W.-J.; TUR-FU HUANG | Toxins | 9 | 6 | |
4 | 2017 | Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet | Chang C.-H.; Chung C.-H.; Tu Y.-S.; Tsai C.-C.; Hsu C.-C.; Peng H.-C.; Tseng Y.J.; TUR-FU HUANG | Arteriosclerosis, Thrombosis, and Vascular Biology | 18 | 20 | |
5 | 2016 | Improved antithrombotic activity and diminished bleeding side effect of a PEGylated alphaiIb beta 3 antagonist, disintegrin | Hsu C.-C.; Chuang W.-J.; Chung C.-H.; Chang C.-H.; Peng H.-C.; TUR-FU HUANG | Thrombosis Research | 6 | 6 | |
6 | 2016 | The disintegrin, trimucrin, suppresses LPS-induced activation of phagocytes primarily through blockade of NF-κB and MAPK activation | Hung Y.-C.; Hsu C.-C.; Chung C.-H.; TUR-FU HUANG | Naunyn-Schmiedeberg's Archives of Pharmacology | 16 | 13 | |
7 | 2016 | Snake Venom Disintegrin Inhibits the Activation of Toll-Like Receptors and Alleviates Sepsis through Integrin alphaVbeta3 Blockade | Hsu C.-C.; Chuang W.-J.; Chung C.-H.; Chang C.-H.; Peng H.-C.; TUR-FU HUANG | Scientific Reports | 9 | 8 | |
8 | 2015 | 4-acetylantroquinonol B suppresses tumor growth and metastasis of hepatoma cells via blockade of translation-dependent signaling pathway and VEGF production | Chang C.-H.; TUR-FU HUANG ; Lin K.-T.; Hsu C.-C.; Chang W.-L.; Wang S.-W.; Ko F.-N.; Peng H.-C.; Chung C.-H. | Journal of Agricultural and Food Chemistry | 14 | 13 | |
9 | 2014 | Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation | Chang C.-H.; Chung C.-H.; Hsu C.-C.; Peng H.-C.; TUR-FU HUANG | Journal of Thrombosis and Haemostasis | 13 | 10 | |
10 | 2013 | Butein inhibits angiogenesis of human endothelial progenitor cells via the translation dependent signaling pathway | Chung C.-H.; Chang C.-H.; Chen S.-S.; Wang H.-H.; Yen J.-Y.; Hsiao C.-J.; Wu N.-L.; Chen Y.-L.; TUR-FU HUANG ; Wang P.-C.; Yeh H.-I.; Wang S.-W. | Evidence-based Complementary and Alternative Medicine | 35 | 25 | |
11 | 2012 | Antirestenosis effect of butein in the neointima formation progression | Chen Y.-N.; TUR-FU HUANG ; Chang C.-H.; Hsu C.-C.; Lin K.-T.; Wang S.-W.; Peng H.-C.; Chung C.-H. | Journal of Agricultural and Food Chemistry | 14 | 11 | |
12 | 2012 | Bp5250 inhibits vascular endothelial growth factor-induced angiogenesis and HIF-1alpha expression on endothelial cells | Lin K.-T.; Lien J.-C.; Chung C.-H.; Kuo S.-C.; TUR-FU HUANG | Naunyn-Schmiedeberg's Archives of Pharmacology | 6 | 6 | |
13 | 2011 | The biologic activity of aggretin/rhodocytin, a snake venom C-type lectin protein (snaclec) | Chung C.-H.; TUR-FU HUANG | Toxins and Hemostasis: From Bench to Bedside | 1 | 0 | |
14 | 2011 | NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A 2 synthesis and calcium entry | Kuo H.-L.; Lien J.-C.; Chang C.-H.; Chung C.-H.; Kuo S.-C.; Hsu C.-C.; Peng H.-C.; TUR-FU HUANG | British Journal of Pharmacology | 5 | 6 | |
15 | 2010 | A novel mechanism of cytokine release in phagocytes induced by aggretin, a snake venom C-type lectin protein, through CLEC-2 ligation | Chang C.-H.; Chung C.-H.; Hsu C.-C.; Huang T.-Y.; TUR-FU HUANG | Journal of Thrombosis and Haemostasis | 38 | 31 | |
16 | 2010 | NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities | Kuo H.-L.; Lien J.-C.; Chung C.-H.; Chang C.-H.; SHYH-CHYI LO ; Tsai I.-C.; Peng H.-C.; Kuo S.-C.; TUR-FU HUANG | Naunyn-Schmiedeberg's Archives of Pharmacology | 29 | 23 | |
17 | 2010 | A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis | Lin K.-T.; Lien J.-C.; Chung C.-H.; Kuo S.-C.; TUR-FU HUANG | European Journal of Pharmacology | 22 | 20 | |
18 | 2009 | The integrin alpha 2 beta 1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production | Chung C.-H.; Lin K.-T.; Chang C.-H.; Peng H.-C.; TUR-FU HUANG | British Journal of Pharmacology | 40 | 36 | |
19 | 2008 | FcγRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2 | TUR-FU HUANG ; Chang C.-H.; Ho P.-L.; Chung C.-H. | Experimental Hematology | 8 | 8 | |
20 | 2008 | The highly specific platelet glycoprotein (GP) VI agonist trowaglerix impaired collagen-induced platelet aggregation ex vivo through matrix metalloproteinase-dependent GPVI shedding | Chang C.-H.; Chung C.-H.; Kuo H.-L.; Hsu C.-C.; TUR-FU HUANG | Journal of Thrombosis and Haemostasis | 24 | 24 | |
21 | 2004 | Aggretin, a snake venom-derived endothelial integrin alpha 2 beta 1 agonist, induces angiogenesis via expression of vascular endothelial growth factor | Chung C.-H.; Wu W.-B.; TUR-FU HUANG | Blood | 43 | 44 | |
22 | 2001 | Aggretin, a C-type lectin protein, induces platelet aggregation via integrin alpha2 beta 1 and gpib in a phosphatidylinositol 3-kinase independent pathway | Chung C.-H.; Peng H.-C.; TUR-FU HUANG | Biochemical and Biophysical Research Communications | 34 | 34 | |
23 | 1999 | Molecular cloning and sequence analysis of aggretin, a collagen-like platelet aggregation inducer | Chung C.-H.; Au L.-C.; TUR-FU HUANG | Biochemical and Biophysical Research Communications | 37 | 34 | |